Previous close | 724.87 |
Open | 723.48 |
Bid | 733.01 x 1000 |
Ask | 733.97 x 1100 |
Day's range | 721.50 - 737.45 |
52-week range | 392.26 - 800.78 |
Volume | |
Avg. volume | 3,066,637 |
Market cap | 697.396B |
Beta (5Y monthly) | 0.37 |
PE ratio (TTM) | 126.47 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 5.20 (0.72%) |
Ex-dividend date | 14 Feb 2024 |
1y target est | N/A |
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]
Besides Wall Street's top -and-bottom-line estimates for Lilly (LLY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Eli Lilly, Novo Nordisk, Merck and AbbVie are part of the Zacks Industry Outlook article.